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Timing optimization of low-dose first-pass
analysis dynamic CT myocardial perfusion
measurement: validation in a swine model
Logan Hubbard, Shant Malkasian, Yixiao Zhao, Pablo Abbona and Sabee Molloi*
Abstract
Background: Myocardial perfusion measurement with a low-dose first-pass analysis (FPA) dynamic computed
tomography (CT) perfusion technique depends upon acquisition of two whole-heart volume scans at the base and
peak of the aortic enhancement. Hence, the objective of this study was to validate an optimal timing protocol for
volume scan acquisition at the base and peak of the aortic enhancement.
Methods: Contrast-enhanced CT of 28 Yorkshire swine (weight, 55 ± 24 kg, mean ± standard deviation) was
performed under rest and stress conditions over 20–30 s to capture the aortic enhancement curves. From these
curves, an optimal timing protocol was simulated, where one volume scan was acquired at the base of the aortic
enhancement while a second volume scan was acquired at the peak of the aortic enhancement. Low-dose FPA
perfusion measurements (PFPA) were then derived and quantitatively compared to the previously validated
retrospective FPA perfusion measurements as a reference standard (PREF). The 32-cm diameter volume CT dose
index, CTDI32vol and size-specific dose estimate (SSDE) of the low-dose FPA perfusion protocol were also determined.
Results: PFPA were related to the reference standard by PFPA = 0.95 · PREF + 0.07 (r = 0.94, root-mean-square
error = 0.27mL/min/g, root-mean-square deviation = 0.04mL/min/g). The CTDI32vol and SSDE of the low-dose FPA
perfusion protocol were 9.2 mGy and 14.6 mGy, respectively.
Conclusions: An optimal timing protocol for volume scan acquisition at the base and peak of the aortic enhancement
was retrospectively validated and has the potential to be used to implement an accurate, low-dose, FPA perfusion
technique.
Keywords: Animal experimentation, Coronary artery disease, Myocardium, Perfusion imaging, Tomography (x-ray
computed)
Key points
 A new first-pass analysis dynamic CT perfusion
technique enables accurate myocardial perfusion
measurement at a low radiation dose, but its clinical
feasibility depends upon optimal acquisition timing.
 Optimal acquisition timing can be determined using
the contrast bolus injection time alone, as a robust
mathematical relation exists between the contrast
bolus injection time and the time-to-peak aortic
enhancement, independent of heart rate or maximal
peak enhancement.
Background
Accurate physiological assessment of coronary artery
disease (CAD) is necessary for objective definition of pa-
tient risk [1–4]. Such physiological assessment of risk is
feasible with dynamic computed tomography (CT) per-
fusion [3, 5, 6], where the spatial distribution of absolute
stress myocardial perfusion in mL/min/g, in combin-
ation with physiological cutoff thresholds, can be used
to reliably stratify patient risk and properly guide inter-
vention [7, 8]. Nevertheless, current dynamic CT perfu-
sion techniques are known to be inaccurate [9–11] and
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have limited craniocaudal coverage. Such techniques also
deliver high effective radiation doses from 5.3 to 10 mSv
per stress or rest perfusion measurement, despite at-
tempts to reduce tube voltage, modulate tube current,
and reduce the number of acquisitions [12–15].
Fortunately, a new first-pass analysis (FPA) dynamic
CT perfusion technique has been shown to improve the
accuracy of perfusion measurement through whole-heart
craniocaudal coverage, with additional potential to re-
duce the effective radiation dose through maximal ac-
quisition number reduction. More specifically, the FPA
perfusion technique is enabled by 320-slice CT scanner
technology that allows the entire myocardium to be ac-
quired in a single gantry rotation. As such, the technique
only requires two optimally timed first-pass volume
scans acquired at the base and the peak of the aortic en-
hancement for accurate perfusion measurement [16–18].
Moreover, given such a sampling scheme, if using a
combined rest and stress perfusion protocol, the second
volume scan of the rest protocol may also be used for
CT angiography if acquired at a diagnostic tube current
[16–18]. While proper timing of the two first-pass vol-
ume scans may be determined through the preemptive
use of a diluted test bolus [19, 20], extra contrast and
radiation dose are required. Alternately, dynamic bolus
tracking-based prospective timing and acquisition of the
two first-pass volume scans may provide a better solu-
tion but remains to be developed and optimized.
Hence, the objective of this study was to retrospect-
ively develop a robust mathematical relation between
the contrast bolus injection time and contrast bolus
time-to-peak for proper prospective acquisition of the
two first-pass volume scans. The central hypothesis was
that the ideal delay time between the two volume scans
equals one half the contrast injection time plus a fixed
dispersion delay. Based on the results, an optimal dy-
namic bolus tracking-based timing protocol was vali-
dated for the low-dose FPA perfusion technique.
Methods
First-pass analysis perfusion measurement theory
The FPA perfusion technique is enabled by 320-slice CT
scanner technology and models the entire myocardium
as a single lumped compartment. Given this model [21],
the average perfusion within the compartment is propor-
tional to the first-pass entry of contrast material mass
over time (dMC/dt), normalized by the incoming con-
trast material concentration (Cin) and compartment
Fig. 1 Contrast bolus injection protocol and bolus dispersion theory. a For all contrast-enhanced imaging, contrast was injected at a fixed rate,
followed by a saline chaser at the same rate. Dynamic imaging of the heart was then performed. b The contrast bolus dispersion and optimal
peak timing theory states that the peak enhancement of the contrast bolus in the aorta occurs at approximately one half the injection time plus
a fixed dispersion delay (T i2 þ d). Note that the V2 volume scan also corresponds to the site of optimal CT angiography
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tissue mass (MT), assuming no contrast material exits
over the measurement duration. By extension, only two
optimally timed first-pass volume scans, labeled V1 and
V2 in Fig. 1, are mathematically necessary for FPA per-
fusion measurement, as previously validated versus inva-
sive fractional flow reserve, quantitative microsphere
perfusion, and ultrasonic flow probe measurement [16–
18]. V1 is defined as a volume scan at approximately the
base of the aortic enhancement, while V2 is defined as a
volume scan at approximately the peak of aortic en-
hancement, i.e., at the same point necessary for optimal
CT angiography [20]. The integrated change in myocar-
dial enhancement (dMC/dt), the average change in myo-
cardial enhancement (ΔHUAVE), the average aortic blood
pool enhancement (Cin), and the voxel-by-voxel change
in myocardial enhancement (ΔHU) between the V1 and
V2 volume scans may then be used in combination with
the total myocardial mass (MT) to derive voxel-by-voxel
perfusion (PFPA) [16–18], as described by Eq. 1:
PFPA ¼ M−1T C−1in
dMc
dt
 
AVE
 ΔHU
ΔHUAVE
ð1Þ
Optimal peak timing theory
Garcia et al. [22] and Han et al. [23] have shown that the
temporal width of the contrast bolus in the aorta is propor-
tional to the volume of the contrast bolus for a given injec-
tion rate. By extension, it follows that for any injection rate,
the contrast bolus injection time should also be predictive
of the temporal width of the contrast bolus in the aorta.
Specifically, upon injection, the contrast bolus is approxi-
mately square in shape, i.e., it has a fixed concentration and
enhancement per unit time, as displayed in Fig. 1a, b. How-
ever, the pulsatile nature of the circulatory system cause
mixing and dispersion, resulting in a broad, approximately
gamma variate contrast bolus geometry by the time it ar-
rives in the aorta, as displayed in Fig. 1b. Nevertheless, such
mixing and dispersion primarily impact the leading and
trailing edges of the bolus. Hence, the temporal center of
the bolus maintains the highest contrast concentration and
peak enhancement where one half the injection time (Ti2 )
plus a fixed dispersion delay (Td) should approximately cor-
respond to the temporal center of the contrast bolus in the
aorta (Tp), as described by Eq. 2 and displayed in Fig. 1b:
Tp ¼ T i2 þ Td ð2Þ
General methods
The study was approved by the Institutional Animal
Care and Use Committee. Contrast-enhanced dynamic
CT imaging was performed under rest and stress condi-
tions in 28 Yorkshire swine (weight 55 ± 24 kg, mean ±
standard deviation), with one to two rest acquisitions
followed by one to three stress acquisitions per animal,
all with the same CT settings. Five of the swine also had
significant coronary artery disease generated with a bal-
loon stenosis method as previously described [16–18].
All data was prospectively acquired and retrospectively
analyzed. First, the contrast bolus geometry in the aorta
was characterized using automatic gamma variate fitting.
From the fit curves, the ideal time-to-peak enhancement
between the base and peak of the aortic enhancement was
derived and compared to one half the contrast injection
time. Next, the ideal time-to-peak enhancement was used
to design a practical, low-dose FPA perfusion protocol,
where the first volume scan (V1) was acquired at approxi-
mately the base of the aortic enhancement through dy-
namic bolus tracking with triggering at 180 HU, while
the second volume scan (V2) was acquired Tp seconds
after V1, at approximately the peak of the aortic en-
hancement. More specifically, Td was incrementally in-
creased from 0 to 4 s and the accuracy of peak
acquisition was assessed in each case, with the best Td
selected for the low-dose FPA perfusion protocol. Fi-
nally, the accuracy of perfusion measurement with the
low-dose FPA perfusion protocol was assessed in a subset
of 14 animals, where low-dose FPA perfusion measure-
ments were quantitatively compared to previously vali-
dated reference standard retrospective FPA perfusion
measurements from the same 14 animals [16–18].
Animal preparation
Anesthesia was induced with Telazol (4.4 mg/kg), keta-
mine (2.2 mg/kg), and xylazine (2.2 mg/kg), and was
maintained with 1.5–2.5% isoflurane (Highland Medical
Equipment, Temecula, CA and Baxter, Deerfield, IL,
USA). Sheaths were placed (5Fr, AVANTI®, Cordis Cor-
poration, Miami Lakes, FL, USA) in each femoral vein
and were used for fluid, adenosine, and contrast material
intravenous administration.
Contrast-enhanced imaging protocol
For each animal, one or two rest acquisitions were per-
formed, followed by one to three stress acquisitions, all
with the same CT settings. For each stress acquisition,
adenosine was infused intravenously for 3 min prior to
and throughout imaging (240 μg adenosine/kg/min,
Model 55-2222, Harvard Apparatus, Holliston, MA,
USA). For each rest and stress acquisition, 1 mL/kg of
contrast material (Isovue 370, Bracco Diagnostics,
Princeton, NJ, USA) was injected (5 mL/s, Empower
CTA, Acist Medical Systems, Eden Prairie, MN, USA)
followed by a saline chaser (0.5 mL/kg) at the same rate.
ECG-gated volume scans were acquired dynamically
with a 320-slice CT scanner (Aquilion One, Toshiba
America Medical Systems, Tustin, CA, USA) over 20–
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30 s to capture base and peak of the aortic enhancement,
as shown in Fig. 1a, b. All volume scans were acquired
as full projection data at 100 kVp and 200 mA with a ro-
tation time of 0.35 s, a collimation of 320 × 0.5 mm, and
a cranio-caudal coverage of 16 cm. A minimum 10-min
delay was employed between consecutive acquisitions to
allow for adequate clearance of contrast material and, if
used, adenosine. All volume scans were retrospectively
reconstructed at 75% of the R-R interval using an adap-
tive iterative dose reduction three-dimensional recon-
struction [24], an FC03 kernel, and a voxel size of 0.43 ×
0.43 × 0.5 mm.
Contrast bolus parameter assessment
For each acquisition, the central lumen of the aorta was
segmented semi-automatically (Vitrea fX version 6.0,
Vital Images, Inc., Minnetonka, MN, USA), yielding a
vascular volume of interest. The volumes of interests
were then used to generate aortic enhancement curves
that were automatically fit via least squares fitting
(LSQCurveFit, MatLab 2013a, MathWorks, Natick, MA,
USA) using a gamma variate function of the form:
EnhancementðtÞ ¼ A
 t
τ
b
 expb

1−t
τ

þ C ð3Þ
where A is the maximum aortic enhancement, t is
time, τ is the decay constant, b is the power, and C is
the initial pre-contrast aortic enhancement. The first
and second derivatives of the gamma fit were also com-
puted. The ideal time-to-peak (Tg) in seconds between
the ideal base and ideal peak of the aortic enhancement
was calculated as the time difference between the
maximum of the second derivative of the gamma vari-
ate fit and the peak of the actual gamma variate fit.
The results were then compared to one half the con-
trast injection time using regression analysis. Example
gamma fits are shown in Fig. 2. The gamma variate fit
results were also analyzed to determine if there were
pair-wise differences in heart rate, time-to-peak, and
peak enhancement between rest and stress conditions.
Additionally, in the five animals with significant sten-
oses, the gamma variate fit results were further ana-
lyzed to determine if there were pair-wise differences
in time-to-peak between rest or stress acquisitions
without stenosis as compared to stress acquisitions
with significant stenosis.
Practical prospective acquisition of the V1 and V2 scans
The optimal peak timing theory was then used to de-
sign a practical low-dose FPA perfusion protocol.
First, dynamic bolus tracking with triggering at
140 HU above the baseline blood pool intensity in
the aorta was simulated (SureStart, Aquilion One,
Canon Medical Systems, Tustin, CA, USA), followed
by systematic selection of V1 as the first electrocar-
diographically gated volume scan after triggering, cor-
responding to approximately the base of the aortic
enhancement. Next, the delay time between V1 and
Fig. 2 Automatic gamma variate fitting of the aortic enhancement in two swine. a The gamma fit (black), first derivative (blue), second derivative
(red), and time-to-peak (Tg) are displayed for a 45-kg animal with a 9-s contrast injection. b The gamma fit (black), first derivative (blue), second
derivative (red), and time-to-peak (Tg) are also displayed for a 95-kg animal with a 19-s contrast injection
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V2 for acquisition of V2 at approximately the peak of
the aortic enhancement was determined. V2 was sys-
tematically selected as the first ECG-gated volume
scan Ti2 þ d s after V1, where the dispersion delay d
was iteratively increased from 0.0 to 4.0 s. For each iter-
ation, the temporal difference between V2 and the ideal
peak was recorded in units of cardiac cycles. The results
were quantitatively compared to determine the dispersion
delay necessary for optimal prospective acquisition of V2
at approximately the peak of the aortic enhancement.
Accuracy of prospective perfusion measurement
The accuracy of the low-dose FPA perfusion protocol
was assessed in a subset of fourteen animals using
previously validated retrospective FPA perfusion mea-
surements as the reference standard. For each acquisi-
tion, V1 and V2 were systematically selected using the
simulated acquisition protocol. Both volume scans were
registered and combined into a maximum intensity
projection image volume, which was segmented
semi-automatically (Vitrea fX version 6.0, Vital Images,
Inc., Minnetonka, MN, USA), yielding the entire myo-
cardium. Low-dose FPA perfusion measurements were
then computed according to Eq. 1 and were compared
to the previously validated reference standard retrospect-
ive FPA perfusion measurements from the same four-
teen animals [16–18]. Additionally, the 32-cm diameter
volume CT dose index, CTDI32vol , of the low-dose FPA
perfusion protocol was recorded, and a size-specific dose
estimate (SSDE) was computed to account for the small
23-cm effective diameter of the swine [25].
Statistical analysis
First, the gamma variate time-to-peak data was related to
the injection time data through regression, root-
mean-square error (RMSE), and root-mean-square devi-
ation (RMSD) analysis, where RMSE and RMSD were
defined as the square root of the standard deviation of the
identity line and fit line residuals, respectively. Next, the
rest and stress data, stenosis data, as well as the optimal V2
acquisition data, were assessed through paired sample t
tests. Finally, all low-dose FPA perfusion measurements
were quantitatively compared to the reference standard
retrospective FPA perfusion measurements using regres-
sion, Bland-Altman, root-mean-square error, root-mean-
square deviation, Lin’s concordance correlation coefficient
[26], and paired sample t testing. Values of p lower than
0.050 were considered as significant. Statistical software
was used for all analysis (MatLab 2013a, MathWorks,
Natick, MA, USA; PS, Version 3.0, Vanderbilt University,
Nashville, TN, USA; SPSS, Version 22, IBM Corporation,
Armonk, NY, USA).
Results
General
A total of 98 measurements were obtained from the 28
animals used in the study. The weight of the animals
was 52.2 ± 14.6 kg (mean ± standard deviation). The
average rest and stress heart rates were 84.86 ± 13.67
and 93.04 ± 12.09 beats per min, respectively.
Contrast bolus parameter assessment
The average gamma fit time-to-peak (Tg) data from each
animal was used for regression analysis. The gamma fit
time-to-peak (Tg) data and one half the injection time
data ( Ti2 ) were related by Tg = 1.01 ·
Ti
2 + 2.28 s, with a
Pearson’s correlation of r = 0.98, a root-mean-square
error of 2.28 s, and a root-mean-square deviation of 2.31
s, as shown in Fig. 3. For all the animals, the average heart
rate, time-to-peak, and peak enhancement under rest and
stress conditions with paired sample t test comparisons
are shown in Table 1. For the five animals with significant
stenosis, the average time-to-peak for rest or stress acqui-
sitions without stenosis was 7.29 ± 0.82 s, while the aver-
age time-to-peak for stress acquisitions in the presence
of significant stenosis was 7.10 ± 0.40 s (p = 0.473).
Optimal prospective acquisition of the V1 and V2 scans
A total of 98 measurements from 28 animals were
assessed. Data from the three best dispersion delays “d”
Fig. 3 Gamma fit time-to-peak data as compared to the one half
injection time data. A total of 98 measurements from 28 animals
were obtained, and the time-to-peak of the aortic enhancement in
each case was retrospectively assessed through automatic gamma
variate fitting. The average gamma fit time-to-peak data from each
animal was then quantitatively compared to the ideal bolus timing
theory through regression analysis. Tg time-to-peak of the aortic
enhancement, defined as the time between the peak of the second
derivative of the gamma fit and the true peak of the gamma fit, Ti
contrast injection time, RMSD root-mean-square deviation, RMSE
root-mean-square error
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in seconds is shown in Table 2. Optimal time delays of
Ti
2 + 0.5,
Ti
2 + 1, and
Ti
2 + 1.5 s resulted in an average car-
diac cycle difference of -0.56 ± 1.79, 0.13 ± 1.85, and
0.86 ± 1.97 (mean ± standard deviation) between V2 and
the ideal peak, respectively. An example of the low-dose
FPA perfusion protocol simulation is shown in Fig. 4.
Accuracy of prospective perfusion measurement
A total of 60 perfusion measurements from 14 animals
were assessed. Low-dose FPA perfusion measurements
(PFPA) were generated using the best dispersion delay “d =
1 s” and were related to the previously validated reference
standard FPA perfusion measurements (PREF) by PFPA =
0.95 ·PREF + 0.07mL/min/g, with a Pearson’s correlation of
r = 0.94, a concordance correlation of ρ = 0.94, a
root-mean-square error of 0.27mL/min/g, and a
root-mean-square deviation of 0.04mL/min/g, as shown in
Fig. 5a, with corresponding Bland-Altman analysis dis-
played in Fig. 5b. Additionally, the mean of the low-dose
measurements was 1.51 ± 0.80mL/min/g, while the mean
of the reference standard measurements was 1.49 ± 0.80 (p
= 0.691). More importantly, the CTDI32vol and SSDE of the
low-dose FPA perfusion protocol were found to be 9.2mGy
and 14.6mGy, respectively, corresponding to an effective
dose and size-specific effective dose of 2.1 and 3.3mSv, re-
spectively, as estimated using the craniocaudal coverage of
16 cm and an adult chest conversion factor of k = 0.014.
Perfusion maps were also generated to compare the spatial
distribution of low-dose FPA perfusion measurements to
the corresponding reference standard FPA perfusion mea-
surements, as shown in Fig. 6.
Discussion
The first goal of the study was to develop a robust mathem-
atical relation between the contrast bolus injection time
and contrast bolus time-to-peak. The results indicate that
over a large range of heart rates (59.74–126.94 beats per
min), injection volumes (28–96mL), and injection times
(5.6–19.2 s), one half the injection time plus a fixed disper-
sion delay of approximately 2.3 s (Ti2 þ 2:3 s ) corresponds
to the ideal time-to-peak aortic enhancement. Furthermore,
in all the animals, there was no significant difference in the
ideal time-to-peak enhancement between rest and stress
conditions (p = 0.411), although stress peak enhance-
ment was significantly lower than rest peak enhance-
ment (p = 0.012) and stress heart rates were
significantly higher than rest heart rates (p = 0.007).
That said, such findings are in agreement with prior
work by Bae et al., which describes an inverse rela-
tionship between cardiac output and peak enhance-
ment [27]. More importantly, in the five animals
with significant stenosis, there were no significant
differences in the ideal time-to-peak enhancement
between rest or stress conditions without stenosis as
compared to stress conditions in the presence of sig-
nificant stenosis (p = 0.473). Given these data, the
contrast bolus injection time is strongly predictive of
the ideal time-to-peak enhancement [22, 23], inde-
pendent of heart rate, peak enhancement, or signifi-
cant stenosis, i.e., the time-to-peak enhancement can
be predicted from the contrast injection protocol
alone. Such findings have important implications.
Not only do they inform that optimal timing for the
new, low-dose FPA perfusion technique is feasible,
they also indicate the potential for optimal timing
for CT angiography, as they enable the peak of the
aortic enhancement to always be acquired independ-
ent of injection protocol.
Using the above relation, the second goal of the
study was to develop a practical acquisition protocol
for the low-dose FPA perfusion technique. The re-
sults indicate that with dynamic bolus tracking, prac-
tical acquisition of V1 at approximately the base of
the aortic enhancement is feasible, with only minor
temporal delays. Moreover, a delay time of Ti2 þ 1 s
between V1 and V2 enabled practical acquisition of
Table 1 Rest and stress comparison
Parameter (n = 28) Rest (mean ± SD) Stress (mean ± SD) p value
Heart rate (beats per min) 84.86 ± 13.67 93.04 ± 12.09 0.007
Gamma fit time-to-peak (s) 7.41 ± 1.93 7.19 ± 1.95 0.411
Peak enhancement (HU) 640.07 ± 150.12 540.07 ± 149.24 0.012
n number of animals assessed, SD standard deviation
Table 2 Low-dose peak acquisition simulation as compared to ideal peak acquisition
Protocol (n = 98) Cardiac cycle difference from peak (beats, mean) p value (comparison with the ideal peak) RMSE (beats)
Ti
2+ 0.5 s -0.56 ± 1.79 0.004 1.87
Ti
2 + 1.0 s 0.13 ± 1.85 0.497 1.84
Ti
2 + 1.5 s 0.86 ± 1.97 0.000 2.14
n number of measurements made in the 28 animals, Ti2 one half of the contrast injection time in seconds, RMSE root-mean-square error
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V2 at approximately the peak of the aortic enhance-
ment, with no significant mean difference in cardiac
cycle offset from the ideal peak (p = 0.497) and a
RMSE of less than two cardiac cycles. Such findings
inform that a low-dose FPA perfusion protocol, as well as
optimal CT angiography, is feasible using dynamic bolus
tracking with reliable peak acquisition timing. By extension,
this work also has the potential to improve the diagnostic
sensitivity of static perfusion measurement. More specific-
ally, Pelgrim et al. [28] found that a fixed timed delay of ap-
proximately 8.3 ± 3.8 s between volume scan triggering and
acquisition resulted in the highest contrast-to-noise ratio
difference between normal and ischemic myocardium. That
said, the deviation in optimal timing was large; hence, one
half the injection time plus a fixed dispersion delay between
volume scan triggering and acquisition could further im-
prove the contrast-to-noise ratio and provide maximal diag-
nostic sensitivity, although prospective validation is still
necessary.
Based on the above results, the final goal of the study
was to validate the accuracy of the low-dose FPA perfu-
sion protocol. Using a time delay of Ti2 þ 1 s between V1
and V2, low-dose FPA perfusion measurements were in
good agreement with the previously validated reference
standard retrospective FPA perfusion measurements,
demonstrating near unity slope, minimal offset, good con-
cordance correlation, and negligible bias, without signifi-
cant differences between measurement means.
Additionally, the low-dose FPA perfusion maps were in
good agreement with the corresponding reference stand-
ard FPA perfusion maps. More importantly, such mea-
surements were achieved at a CTDI32vol and SSDE of only
9.2 mGy and 14.6mGy, respectively, corresponding to an
effective dose and size-specific effective dose of 2.1 and
3.3 mSv, substantially lower than the 5.3–10mSv effective
dose of current dynamic CT perfusion techniques. That
said, other groups like van Assen et al. [29] have attempted
to reduce the number of volume scans necessary for perfu-
sion measurement. Unfortunately, given the mathematical
Fig. 4 Low-dose FPA perfusion protocol simulation. The aortic gamma
variate fit was used to simulate dynamic bolus tracking-based triggering,
where V1 was systematically selected as the first electrocardiographically
gated volume scan after triggering, while V2 was systematically selected
as the first electrocardiographically gated volume scan occurring T i2 + 0
to 4.0 s after V1. The cardiac cycle distance of V2 from the ideal peak
enhancement (red triangle) was then recorded. Note that the V2 volume
scan also corresponds to the site of optimal CT angiography
Fig. 5 Low-dose first-pass analysis (FPA) perfusion measurements as compared to the reference standard retrospective FPA perfusion
measurements. A total of 60 perfusion measurements from 14 animals were assessed. a Regression analysis comparing the simulated low-dose
FPA perfusion measurements to the previously validated reference standard retrospective FPA perfusion measurements is displayed. b
Corresponding Bland-Altman analysis is also shown
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limitations of most perfusion models combined with the
limited craniocaudal coverage of standard CT scanner tech-
nology, lower temporal sampling rates invariably worsen
the inaccuracies of current dynamic CT perfusion tech-
niques [12–15, 29]. Fortunately, the low-dose FPA perfu-
sion technique is fundamentally different from current
dynamic CT perfusion techniques in that only two
whole-heart volume scans are necessary for accurate perfu-
sion measurement, as previously validated versus invasive
fractional flow reserve (FFR), quantitative microsphere per-
fusion, and ultrasonic flow probe measurement [16–18].
More importantly, given the results of this work, practical
implementation of the low-dose FPA perfusion technique
may now be achieved.
This study has limitations. First, while a range of swine
weights and injections times were used, the animals were
undersized as compared to an average human cardiac
patient. Hence, additional work in larger animals may
still be necessary to confirm that the optimal timing
protocol is robust. Second, all contrast injections were
made at a fixed rate of 5 mL/s, i.e., no other injection
rates were assessed. Nevertheless, as the optimal timing
protocol is predominantly a function of injection time, it
should accommodate the use of any injection rate, al-
though additional work may still be necessary to deter-
mine if a dispersion delay of 1 s remains valid for
different injection rates. Third, only five swine in this
study had balloon stenoses; hence, additional work in
more swine with significant cardiac disease may still be
necessary to better assess the performance of the opti-
mal timing protocol. Fourth, the optimal timing protocol
was developed and validated retrospectively using data
from a wide-volume CT scanner, i.e., the triggering
scheme and subsequent timing of V1 and V2 acquisition
may be scanner specific. As such, additional validation
of the optimal timing protocol with other CT systems
may still necessary to determine if the fixed dispersion
delay of 1 s remains robust. Finally, while simulated
low-dose FPA perfusion measurements performed well
as compared to the previously validated reference stand-
ard retrospective FPA perfusion measurements [16–18],
true prospective acquisition of V1 and V2 using the
optimal timing protocol was not assessed; hence, add-
itional prospective work in more animals may still be
necessary. Alternatively, if prospective acquisition of
V1 and V2 proves difficult, the timing of V1 and V2
acquisition may also be predicted through the pre-
emptive use of a low-dose diluted test bolus acquisi-
tion [19, 20], although the overall contrast and
radiation dose associated with low-dose FPA perfusion
measurement will be increased.
In conclusion, an optimal timing protocol for accurate,
low-dose, FPA dynamic CT perfusion measurement was
retrospectively simulated and validated in 28 swine over a
range of heart rates, injection volumes, and injection time
intervals. Using dynamic bolus tracking, the protocol re-
sulted in robust acquisition of V1 at approximately the
base of the aortic enhancement, with robust acquisition of
V2 Ti2 þ 1 s after V1 at approximately the peak of the aor-
tic enhancement. Such findings have important implica-
tions in that they enable practical, low-dose FPA perfusion
Fig. 6 Quantitative voxel-by-voxel first-pass analysis (FPA) perfusion maps. Low-dose rest (top left) and stress (top right) FPA perfusion maps are
displayed as compared to reference standard retrospective rest (bottom left) and stress (bottom right) FPA perfusion maps. The color bar
indicates myocardial perfusion in mL/min/g.
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measurement at a CTDI32vol and SSDE of only 9.2 mGy and
14.6mGy, respectively. In summary, the optimal timing
protocol was retrospectively validated in 28 swine and has
the potential to be used for practical implementation of a
new, low-dose FPA perfusion technique.
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